Antigen release kinetics in the phagosome are critical to cross-presentation efficiency

被引:41
作者
Howland, Shanshan W. [1 ]
Wittrup, K. Dane [1 ,2 ]
机构
[1] MIT, Dept Biol Engn, Cambridge, MA 02139 USA
[2] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
关键词
D O I
10.4049/jimmunol.180.3.1576
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cross-presentation of exogenous Ags in MHC class I molecules by dendritic cells is the underlying basis for many developing immunotherapies and vaccines. In the phagosome-to-cytosol pathway, Ags in phagocytosed particles must become freely soluble before being exported to the cytosol, but the kinetics of this process has yet to be fully appreciated. We demonstrate with a yeast vaccine model that the rate of Ag release in the phagosome directly affects cross-presentation efficiency, with an apparent time limit of similar to 25 min postphagocytosis for Ag release to be productive. Ag expressed on the yeast surface is cross-presented much more efficiently than Ag trapped in the yeast cytosol by the cell wall. The cross-presentation efficiency of yeast surface-displayed Ag can be increased by the insertion of linkers susceptible to cleavage in the early phagosome. Ags indirectly attached to yeast through Ab fragments are less efficiently cross-presented when the Ab dissociation rate is extremely slow.
引用
收藏
页码:1576 / 1583
页数:8
相关论文
共 45 条
[1]   Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo [J].
Accapezzato, D ;
Visco, V ;
Francavilla, V ;
Molette, C ;
Donato, T ;
Paroli, M ;
Mondelli, MU ;
Doria, M ;
Torrisi, MR ;
Barnaba, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06) :817-828
[2]   Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens [J].
Ackerman, AL ;
Kyritsis, C ;
Tampé, R ;
Cresswell, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (22) :12889-12894
[3]   A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells [J].
Ackerman, Anne L. ;
Giodini, Alessandra ;
Cresswell, Peter .
IMMUNITY, 2006, 25 (04) :607-617
[4]   TAP1-INDEPENDENT LOADING OF CLASS-I MOLECULES BY EXOGENOUS VIRAL-PROTEINS [J].
BACHMANN, MF ;
OXENIUS, A ;
PIRCHER, H ;
HENGARTNER, H ;
ASHTONRICHARDT, PA ;
TONEGAWA, S ;
ZINKERNAGEL, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) :1739-1743
[5]   Human dendritic cell interactions with whole recombinant yeast: Implications for HIV-1 vaccine development [J].
Barron, Michelle A. ;
Blyveis, Naomi ;
Pan, Samuel C. ;
Wilson, Cara C. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2006, 26 (03) :251-264
[6]   Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S [J].
Baumgrass, R ;
Williamson, MK ;
Price, PA .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (03) :447-455
[7]   Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity [J].
Boder, ET ;
Midelfort, KS ;
Wittrup, KD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (20) :10701-10705
[8]   Yeast surface display for screening combinatorial polypeptide libraries [J].
Boder, ET ;
Wittrup, KD .
NATURE BIOTECHNOLOGY, 1997, 15 (06) :553-557
[9]   Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast [J].
Breinig, F ;
Heintel, T ;
Schumacher, A ;
Meyerhans, A ;
Schmitt, MJ .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2003, 38 (03) :231-239
[10]   Peptide-based vaccines for cancer immunotherapy [J].
Brinkman, JA ;
Fausch, SC ;
Weber, JS ;
Kast, WM .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (02) :181-198